Umoja Biopharma, an oncology company, announced on Tuesday that it has named David Fontana PhD as its new chief business and strategy officer.
Dr Fontana has served as an executive in the Cell Therapy Franchise and part of the Lymphoma Disease Strategy Team at Bristol Myers Squibb. He has served as vice president of Immuno-Oncology at Pfizer.
Dr Fontana has a PhD in Pharmacology from Wayne State University and PMP certification from the Project Management Institute.
Bioforum, The Data Masters names new President
VolitionRx names new Chief Medical Officer
Quotient Sciences announces new appointments
Syndax Pharmaceuticals names new chief commercial officer
Everest Medicines names new chief medical officer and chief product officer
D3 Bio names new independent board member
Rigel Pharmaceuticals names new executive vice president and chief medical officer
Telix Pharmaceuticals names new group chief operating officer